Protecting commercially confidential and personal data while using the EU Clinical Trials Information System (CTIS) has proved a tricky aspect of the Clinical Trials Regulation (CTR) that has ushered in strict transparency requirements.
While the recent EU guidance on this topic addressed “some fundamental concepts with which industry has been struggling,” further clarifications...